[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 81]
[FORM 20-F o OR x OR o For the transition period from to OR o Date of event requiring this shell company report: China Cord Blood Corporation Cayman Islands (Jurisdiction of incorporation or organization) 48th Floor, Bank of China Tower 1 Garden Road Central, Hong Kong S.A.R. Albert Chen +852 3605 81]
[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 201 7 Added 20,566 New Subscribers in 4Q17 4Q17 Revenue Amounted to RMB202.0 Million ($29.3 Million) 4Q17 Operating Income Amounted to RMB56.3 Million ($8.2 Million) Conference Call to be Held on Ju]
[China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 201 7 Added 20,566 New Subscribers in 4Q17 4Q17 Revenue Amounted to RMB202.0 Million ($29.3 Million) 4Q17 Operating Income Amounted to RMB56.3 Million ($8.2 Million) Conference Call to be Held on Ju]
[April 13, 2017 The Board of Directors 48/F., Bank of China Tower, 1 Garden Road, Central, Hong Kong Non-binding Acquisition Proposal dated April 27, 2015 Re: Ladies and Gentlemen: Reference is made to above-described non-binding proposal. In view of the developments regarding Golden Meditech Holding]
[April 13, 2017 The Board of Directors 48/F., Bank of China Tower, 1 Garden Road, Central, Hong Kong Non-binding Acquisition Proposal dated April 27, 2015 Re: Ladies and Gentlemen: Reference is made to above-described non-binding proposal. In view of the developments regarding Golden Meditech Holding]
[China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding Going Private Proposal HONG KONG, China, April 13, 2017 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoiet]
[China Cord Blood Corporation Announces Termination of Evaluation and Negotiation Regarding Going Private Proposal HONG KONG, China, April 13, 2017 China Cord Blood Corporation (NYSE: CO) (CCBC or the Company), Chinas leading provider of cord blood collection, laboratory testing, hematopoiet]
[JOINT FILING AGREEMENT Dated: April 10, 2017 GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED GOLDEN MEDITECH HOLDINGS LIMITED] []
[JOINT FILING AGREEMENT Dated: April 10, 2017 GOLDEN MEDITECH STEM CELLS (BVI) COMPANY LIMITED GOLDEN MEDITECH HOLDINGS LIMITED] []
